Keith A. McLean, M.D., cardiologist, joins Norton King’s Daughters’ Health in Madison, Indiana
Norton Heart & Vascular Institute welcomes Keith A. McLean, M.D., cardiologist, to Norton King’s Daughters’ Health in Madison, Indiana. The office is located in the Norton King’s Daughters’ Health Downtown Medical Building at 630 N. […]
View more
Kevin Graham, M.D., joins Norton Heart & Vascular Institute Structural Heart Program
Kevin A. Graham, M.D., a cardiothoracic surgeon, has joined Norton Heart & Vascular Institute. Dr. Graham, who earned his medical degree from Indiana University, Indianapolis, and completed his residency there, has been practicing in Illinois. […]
View more
Ischemic heart disease in women may not show up on standard tests
Ischemic heart disease in women can lead to a heart attack, but this risk may go unnoticed. This is because a patient’s diagnostic coronary angiogram shows “clear” arteries. “When diagnosing women for ischemic heart disease, [...]
View more
Borderline hypertension poses myocardial dysfunction risks
Borderline hypertension or subclinical hypertension is a substrate for myocardial dysfunction, and patients can go for a long time with hypertension that isn’t clinically recognized, according to a heart failure specialist at Norton Heart & […]
View more
Hypertension in women and its consequences
The risks and consequences of hypertension in women differ from those in men and change throughout women’s lifetimes. Overall, hypertension in women is less prevalent than in men until age 60 and becomes more prevalent […]
View more
Norton Heart & Vascular Institute expands Women’s Heart Program
Norton Heart & Vascular Institute launched a Women’s Heart Program in 1995. Today it has expanded to include more providers and services for a region where heart disease, especially in women, is a deadly issue. [...]
View more
CT-FFR analysis shows patient’s level of cardiac obstruction and location, guiding treatment
The patient In July 2022, a 45-year-old male with a six-year history of chest pain went to the emergency room complaining of chest discomfort and shortness of breath over the previous two weeks. He was [...]
View more
Advances in hyperlipidemia medications put cholesterol goals in reach for more patients
Diet and exercise many times are not enough to lower the risk of hyperlipidemia (HLD). As we’ve learned over the years, genetics can play the biggest role. Fortunately, we now have treatments we didn’t have […]
View more
Advanced Heart Failure Referral Guidelines
When symptoms of heart failure begin progressing or patients start decompensating, there is a brief opportunity for referral to an advanced heart failure center. The American Heart Association calls this the “golden window.” Providers should […]
View more
Mavacamten, a new treatment for hypertrophic cardiomyopathy is changing lives
A new, first-in-its-class treatment for hypertrophic cardiomyopathy, mavacamten, has been a game-changer for my patients with obstruction. In April, the Food and Drug Administration (FDA) gave breakthrough therapy designation and orphan drug designation for the […]
View more
Neurohormonal blockade in heart failure
Newly diagnosed heart failure patients have a three-month window of care crucial to their likelihood of recovery. The difference can be returning to a normal life versus awaiting a heart transplant or mechanical circulatory support […]
View more
Lauren R. Albers, M.D., joins Norton Heart & Vascular Institute to focus on women’s cardiology
Lauren R. Albers, M.D., has joined Norton Heart & Vascular Institute to focus on women’s cardiology. Dr. Albers, who completed her fellowship in cardiovascular medicine at the UofL School of Medicine, joins the Norton Heart […]
View more